Pub Date : 2025-11-11eCollection Date: 2025-07-01DOI: 10.71480/nmj.v66i4.782
Emediong Asuka, Jesse Odion
Statins, widely prescribed for their efficacy in reducing low-density lipoprotein cholesterol (LDL-C) and preventing atherosclerotic cardiovascular disease, are generally well tolerated. However, muscle-related adverse effects, particularly statin-associated myopathy, can significantly impact patient function and adherence. This case report describes an 83-year-old man who developed progressive proximal muscle weakness, fatigue, and recurrent falls following initiation of high-dose atorvastatin after a ST-elevation myocardial infarction. Clinical and laboratory evaluation, along with the temporal association and improvement after drug withdrawal, supported a diagnosis of self-limited toxic statin myopathy. Extensive differential diagnosis excluded other neuromuscular, endocrine, and vascular causes. Prompt discontinuation of atorvastatin, supportive care, and physiotherapy led to marked functional recovery. This case highlights the spectrum of statin-induced muscle toxicity, emphasises diagnostic vigilance in older adults, and underscores the importance of personalised therapy and early intervention to mitigate adverse outcomes.
{"title":"Statin-Induced Toxic Myopathy Masquerading as Recurrent Falls and De-Conditioning in an Older Adult.","authors":"Emediong Asuka, Jesse Odion","doi":"10.71480/nmj.v66i4.782","DOIUrl":"10.71480/nmj.v66i4.782","url":null,"abstract":"<p><p>Statins, widely prescribed for their efficacy in reducing low-density lipoprotein cholesterol (LDL-C) and preventing atherosclerotic cardiovascular disease, are generally well tolerated. However, muscle-related adverse effects, particularly statin-associated myopathy, can significantly impact patient function and adherence. This case report describes an 83-year-old man who developed progressive proximal muscle weakness, fatigue, and recurrent falls following initiation of high-dose atorvastatin after a ST-elevation myocardial infarction. Clinical and laboratory evaluation, along with the temporal association and improvement after drug withdrawal, supported a diagnosis of self-limited toxic statin myopathy. Extensive differential diagnosis excluded other neuromuscular, endocrine, and vascular causes. Prompt discontinuation of atorvastatin, supportive care, and physiotherapy led to marked functional recovery. This case highlights the spectrum of statin-induced muscle toxicity, emphasises diagnostic vigilance in older adults, and underscores the importance of personalised therapy and early intervention to mitigate adverse outcomes.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1672-1680"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145867170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Stroke is a major cause of morbidity and mortality globally, with a particularly high burden in low- and middle-income countries such as Nigeria. Early identification of biomarkers, such as serum Galectin-3, which plays a role in inflammation and tissue remodeling, may improve diagnostic accuracy and patient outcomes in acute ischemic stroke. This study aimed to compare serum Galectin-3 levels between patients with acute ischemic stroke and age- and sex-matched stroke-free controls.
Methodology: A prospective comparative cross-sectional study was conducted at the University of Ilorin Teaching Hospital, Ilorin, Nigeria. A total of 100 first-ever acute ischemic stroke patients and 100 apparently healthy controls were recruited. Serum Galectin-3 levels were measured using an enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed to compare Galectin-3 levels between groups using the Statistical Package for the Social Sciences (SPSS), version 24.0.
Results: The median serum Galectin-3 level was significantly higher in stroke patients compared to controls [60 (55.00-63.00) vs 56 (49.00-62.00), p = 0.003]. The two groups were comparable in age and sex distribution, but hypertension and diabetes were significantly more prevalent among stroke patients. Elevated serum Galectin-3 levels were positively associated with stroke diagnosis.
Conclusion: Serum Galectin-3 is significantly elevated in acute ischemic stroke patients compared to stroke-free individuals. Galectin-3 could serve as an important biomarker for acute ischemic stroke, aiding in timely diagnosis and management.
背景:卒中是全球发病和死亡的主要原因,在尼日利亚等低收入和中等收入国家造成的负担特别高。早期识别生物标志物,如在炎症和组织重塑中起作用的血清半乳糖凝集素-3,可能提高急性缺血性卒中的诊断准确性和患者预后。本研究旨在比较急性缺血性卒中患者与年龄和性别匹配的无卒中对照者血清半乳糖凝集素-3水平。方法:在尼日利亚伊洛林的伊洛林大学教学医院进行了前瞻性比较横断面研究。总共招募了100名首次急性缺血性中风患者和100名明显健康的对照组。采用酶联免疫吸附试验(ELISA)测定血清半乳糖凝集素-3水平。使用社会科学统计软件包(SPSS) 24.0版本进行统计分析,比较各组间半乳糖凝集素-3水平。结果:脑卒中患者血清半凝集素-3水平中位数明显高于对照组[60 (55.00-63.00)vs 56 (49.00-62.00), p = 0.003]。两组在年龄和性别分布上是相似的,但高血压和糖尿病在中风患者中更为普遍。血清半乳糖凝集素-3水平升高与卒中诊断呈正相关。结论:急性缺血性脑卒中患者血清半乳糖凝集素-3明显升高。半乳糖凝集素-3可作为急性缺血性脑卒中的重要生物标志物,有助于及时诊断和治疗。
{"title":"Serum Galectin-3 as a Prognostic Biomarker in Acute Ischemic Stroke: A Comparative Cross-Sectional Study.","authors":"Aminat Kehinde Bakare, Olusola Omotayo Adebisi, Olusegun Ige Adebisi, Hameedat Opeyemi Omoyele-Abdulssalam, Timothy Adetokunbo Vaughan, Oluyomi Oluseun Okunola, Wasiu Kolawole Wahab","doi":"10.71480/nmj.v66i4.875","DOIUrl":"10.71480/nmj.v66i4.875","url":null,"abstract":"<p><strong>Background: </strong>Stroke is a major cause of morbidity and mortality globally, with a particularly high burden in low- and middle-income countries such as Nigeria. Early identification of biomarkers, such as serum Galectin-3, which plays a role in inflammation and tissue remodeling, may improve diagnostic accuracy and patient outcomes in acute ischemic stroke. This study aimed to compare serum Galectin-3 levels between patients with acute ischemic stroke and age- and sex-matched stroke-free controls.</p><p><strong>Methodology: </strong>A prospective comparative cross-sectional study was conducted at the University of Ilorin Teaching Hospital, Ilorin, Nigeria. A total of 100 first-ever acute ischemic stroke patients and 100 apparently healthy controls were recruited. Serum Galectin-3 levels were measured using an enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed to compare Galectin-3 levels between groups using the Statistical Package for the Social Sciences (SPSS), version 24.0.</p><p><strong>Results: </strong>The median serum Galectin-3 level was significantly higher in stroke patients compared to controls [60 (55.00-63.00) vs 56 (49.00-62.00), p = 0.003]. The two groups were comparable in age and sex distribution, but hypertension and diabetes were significantly more prevalent among stroke patients. Elevated serum Galectin-3 levels were positively associated with stroke diagnosis.</p><p><strong>Conclusion: </strong>Serum Galectin-3 is significantly elevated in acute ischemic stroke patients compared to stroke-free individuals. Galectin-3 could serve as an important biomarker for acute ischemic stroke, aiding in timely diagnosis and management.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1423-1429"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145867103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11eCollection Date: 2025-07-01DOI: 10.71480/nmj.v66i4.1056
Kelechi E Okonta
Background: The study aimed to determine the correlation between the number of significant rib fractures in patients with blunt chest trauma (BCT) and the amount of haemothorax as recorded by Closed Thoracostomy Tube Drainage (CTTD).
Methodology: This was a cross-sectional study of all patients with significant rib fractures following BCT over a period of two years. "Significant rib fractures" was defined as the fracture of 3 or more ribs with 50% or more displacement of each fractured rib edge. Patients with massive haemothorax, patients with severe neurological, or patients who required emergency thoracotomy were excluded.The diagnosis of rib fracture was made by standard chest radiograph or Chest Tomography Scan.Descriptive analyses were reported as mean and standard deviation (SD) for the variables. Pearson correlation test was conducted to test the relationship between the numbers of fractured ribs with the amount of haemothorax as recorded by CTTD with P-value significant at<0.001.
Result: Sixteen patients who met the criteria were analysed with a mean age of 46.5years±(SD16.47), the mean number of fractured ribs was 4.5±1.37, the mean amount of drained blood was 605.3ml±(SD244.3) and the mean amount of drained blood per the number of each fractured rib was 134.5ml±54.29.The Pearson Correlation test was strongly positive at,r=0.80 with (P< 0.001).
Conclusion: In any patient with BCT, and with fractured of 3 or more ribs, there may be the need to institute a CTTD irrespective of whether the chest radiograph or chest computerized scan shows immediate evidence of significant haemothorax.
{"title":"What is the relationship between the Number of Significant rib fractures and Haemothorax in adults with blunt chest trauma?","authors":"Kelechi E Okonta","doi":"10.71480/nmj.v66i4.1056","DOIUrl":"10.71480/nmj.v66i4.1056","url":null,"abstract":"<p><strong>Background: </strong>The study aimed to determine the correlation between the number of significant rib fractures in patients with blunt chest trauma (BCT) and the amount of haemothorax as recorded by Closed Thoracostomy Tube Drainage (CTTD).</p><p><strong>Methodology: </strong>This was a cross-sectional study of all patients with significant rib fractures following BCT over a period of two years. \"Significant rib fractures\" was defined as the fracture of 3 or more ribs with 50% or more displacement of each fractured rib edge. Patients with massive haemothorax, patients with severe neurological, or patients who required emergency thoracotomy were excluded.The diagnosis of rib fracture was made by standard chest radiograph or Chest Tomography Scan.Descriptive analyses were reported as mean and standard deviation (SD) for the variables. Pearson correlation test was conducted to test the relationship between the numbers of fractured ribs with the amount of haemothorax as recorded by CTTD with P-value significant at<0.001.</p><p><strong>Result: </strong>Sixteen patients who met the criteria were analysed with a mean age of 46.5years±(SD16.47), the mean number of fractured ribs was 4.5±1.37, the mean amount of drained blood was 605.3ml±(SD244.3) and the mean amount of drained blood per the number of each fractured rib was 134.5ml±54.29.The Pearson Correlation test was strongly positive at,r=0.80 with (<i>P</i>< 0.001).</p><p><strong>Conclusion: </strong>In any patient with BCT, and with fractured of 3 or more ribs, there may be the need to institute a CTTD irrespective of whether the chest radiograph or chest computerized scan shows immediate evidence of significant haemothorax.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1647-1651"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746333/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145867206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11eCollection Date: 2025-07-01DOI: 10.71480/nmj.v66i4.981
Elizabeth Onazahi Ajogun, Elizabeth Eberechi Oyenusi, Abiola Olufunmilayo Oduwole, Maryann Ugochi Ibekwe
Background: Normal blood glucose supply and metabolism are of utmost importance for growth and normal brain development in the foetus and newborn. Disorders in glucose supply or metabolism can result in hypoglycaemia or hyperglycaemia. Considering the increasing trend of caesarean section (CS) worldwide, including Nigeria, it is important to determine the incidence and type of dysglycaemia in neonates delivered by CS. The study objective was to compare the blood glucose (BG) levels of newborns delivered by CS with those by vaginal delivery (VD).
Methodology: This was a prospective observational study of 164 neonates, of which 85 were delivered through CS and 79 through VD. A pretested questionnaire was used to obtain information on sociodemographic variables, gestational age, feeding time of the new-born and maternal fasting time, while BG was determined using Accu-chek Multiclix. Every tenth sample was also tested in the laboratory for quality control.
Results: The mean (SD) cord blood glucose level was lower in the CS (68.7(10.1) mg/dl) than VD neonates (80.9(11.5) mg/dl, p = <0.001). The mean (SD) blood glucose level at 2 hours of life was also lower in CS (62.5(10.0) mg/dl) than VD neonates (71.2(10.9) mg/dl, p = <0.001). Factors that were significantly associated with cord BG levels were gestational age, maternal fasting time and mode of delivery. At two hours of life, cord blood, neonatal feeding time, gestational age and birth weight were significantly associated with neonatal BG levels.
Conclusion: Cord and neonatal BG were significantly lower in neonates who were delivered via CS compared to those delivered vaginally.
背景:正常的血糖供应和代谢对胎儿和新生儿的生长发育和正常的大脑发育至关重要。葡萄糖供应或代谢紊乱可导致低血糖或高血糖。考虑到包括尼日利亚在内的世界范围内剖宫产(CS)的增加趋势,确定剖腹产分娩的新生儿血糖异常的发生率和类型是很重要的。研究目的是比较经阴道分娩(VD)和经阴道分娩(CS)分娩的新生儿的血糖(BG)水平。方法:这是一项164名新生儿的前瞻性观察研究,其中85名通过CS分娩,79名通过VD分娩。采用预测问卷获取社会人口学变量、胎龄、新生儿喂养时间和产妇禁食时间等信息,同时使用Accu-chek Multiclix测定BG。每10份样品也在实验室进行质量控制测试。结果:CS组新生儿脐带血血糖平均值(SD) (68.7(10.1) mg/dl)低于VD组新生儿(80.9(11.5)mg/dl), p =结论:CS组新生儿脐带血和新生儿BG明显低于顺产组。
{"title":"Comparison of Blood Glucose Levels in Caesarean and Vaginally Delivered Newborns at Lagos University Teaching Hospital, Nigeria.","authors":"Elizabeth Onazahi Ajogun, Elizabeth Eberechi Oyenusi, Abiola Olufunmilayo Oduwole, Maryann Ugochi Ibekwe","doi":"10.71480/nmj.v66i4.981","DOIUrl":"10.71480/nmj.v66i4.981","url":null,"abstract":"<p><strong>Background: </strong>Normal blood glucose supply and metabolism are of utmost importance for growth and normal brain development in the foetus and newborn. Disorders in glucose supply or metabolism can result in hypoglycaemia or hyperglycaemia. Considering the increasing trend of caesarean section (CS) worldwide, including Nigeria, it is important to determine the incidence and type of dysglycaemia in neonates delivered by CS. The study objective was to compare the blood glucose (BG) levels of newborns delivered by CS with those by vaginal delivery (VD).</p><p><strong>Methodology: </strong>This was a prospective observational study of 164 neonates, of which 85 were delivered through CS and 79 through VD. A pretested questionnaire was used to obtain information on sociodemographic variables, gestational age, feeding time of the new-born and maternal fasting time, while BG was determined using Accu-chek Multiclix. Every tenth sample was also tested in the laboratory for quality control.</p><p><strong>Results: </strong>The mean (SD) cord blood glucose level was lower in the CS (68.7(10.1) mg/dl) than VD neonates (80.9(11.5) mg/dl, p = <0.001). The mean (SD) blood glucose level at 2 hours of life was also lower in CS (62.5(10.0) mg/dl) than VD neonates (71.2(10.9) mg/dl, p = <0.001). Factors that were significantly associated with cord BG levels were gestational age, maternal fasting time and mode of delivery. At two hours of life, cord blood, neonatal feeding time, gestational age and birth weight were significantly associated with neonatal BG levels.</p><p><strong>Conclusion: </strong>Cord and neonatal BG were significantly lower in neonates who were delivered via CS compared to those delivered vaginally.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1526-1538"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145866893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Immature teeth must be managed by apexification as there is no definite apical stop. Use of intracanal medicaments prior to apexification affect the sealing ability of apical plug. Present study was done to compare the effect of various intracanal medicaments: Metapex, Chlorhexidine digluconate, Curcuma longa, and Triple antibiotic paste (TAP) on the sealing ability of MTA and Hydroxyapatite as an apical plug.
Methodology: 130 single-rooted teeth were divided into two experimental groups (n=60 each) [Group I: MTA; Group II: Hydroxyapatite], and two control groups (n=5 each) [Group IIIA: MTA; Group IIIB: Hydroxyapatite] based on the apical plug used. Experimental groups were subdivided, based on intracanal medicaments [Group IA and IIA - Metapex; Group IB and IIB - 2% Chlorhexidine digluconate, Group IC and IIC - Curcuma longa, Group ID and IID - TAP]. After biomechanical preparation, simulation of immature apex was done using peeso-reamer. Intracanal medicaments were placed, and study samples were incubated for 7 days. Then all medicaments were removed using H-files, followed by retrograde apical placement, obturation, and restoration. Samples were subjected to dye penetration test, followed by clearing procedure. Apical microleakage was assessed using stereomicroscope at 40X. Data collected was subjected to statistical analysis using SPSS version 20.0 (p=0.05).
Results: Apical dye penetration was minimum in control group, followed by Group IB (0.17±.46) < IIB (0.53±.57) < IIC (0.90±.96) < IID (0.93±.59) < IC (1.83±.83) < ID (1.91±.81) < IIA (2.13±.81) < IA (2.31±.73).Intragroup comparison for apical microleakage was statistically significant (p<0.001), whereas intergroup comparisons were statistically significant except for group IA v/s IIA, IB v/s IIB, IC v/s IIA, ID v/s IIA.
Conclusion: Hydroxyapatite showed better sealing ability than MTA with all intracanal medicaments. Sealing ability was minimal with Metapex, followed by Turmeric, TAP, and 2% Chlorhexidine.
{"title":"Comparative evaluation of intracanal medicaments on sealing ability of MTA and Hydroxyapatite apical plug in simulated immature teeth - An in vitro study.","authors":"Kanika Gupta Verma, Shubhada Kasat, Sanad Kumar Singh Solanki, Abhinaba Das, Naseebia Khan, Dimple Kishan Tirale","doi":"10.71480/nmj.v66i4.1009","DOIUrl":"10.71480/nmj.v66i4.1009","url":null,"abstract":"<p><strong>Background: </strong>Immature teeth must be managed by apexification as there is no definite apical stop. Use of intracanal medicaments prior to apexification affect the sealing ability of apical plug. Present study was done to compare the effect of various intracanal medicaments: Metapex, Chlorhexidine digluconate, Curcuma longa, and Triple antibiotic paste (TAP) on the sealing ability of MTA and Hydroxyapatite as an apical plug.</p><p><strong>Methodology: </strong>130 single-rooted teeth were divided into two experimental groups (n=60 each) [Group I: MTA; Group II: Hydroxyapatite], and two control groups (n=5 each) [Group IIIA: MTA; Group IIIB: Hydroxyapatite] based on the apical plug used. Experimental groups were subdivided, based on intracanal medicaments [Group IA and IIA - Metapex; Group IB and IIB - 2% Chlorhexidine digluconate, Group IC and IIC - Curcuma longa, Group ID and IID - TAP]. After biomechanical preparation, simulation of immature apex was done using peeso-reamer. Intracanal medicaments were placed, and study samples were incubated for 7 days. Then all medicaments were removed using H-files, followed by retrograde apical placement, obturation, and restoration. Samples were subjected to dye penetration test, followed by clearing procedure. Apical microleakage was assessed using stereomicroscope at 40X. Data collected was subjected to statistical analysis using SPSS version 20.0 (p=0.05).</p><p><strong>Results: </strong>Apical dye penetration was minimum in control group, followed by Group IB (0.17±.46) < IIB (0.53±.57) < IIC (0.90±.96) < IID (0.93±.59) < IC (1.83±.83) < ID (1.91±.81) < IIA (2.13±.81) < IA (2.31±.73).Intragroup comparison for apical microleakage was statistically significant (p<0.001), whereas intergroup comparisons were statistically significant except for group IA v/s IIA, IB v/s IIB, IC v/s IIA, ID v/s IIA.</p><p><strong>Conclusion: </strong>Hydroxyapatite showed better sealing ability than MTA with all intracanal medicaments. Sealing ability was minimal with Metapex, followed by Turmeric, TAP, and 2% Chlorhexidine.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1587-1596"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145866878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11eCollection Date: 2025-07-01DOI: 10.71480/nmj.v66i4.1013
Leeleebari Rachael Deekae, Daniel Lekue Denebari, Happiness Chinaza Dick, Daprim Samuel Ogaji
Background: Digital technology offers promising solutions for monitoring pregnant women but client's readiness for its adoption in Nigeria remains underexplored. This study assessed antenatal clients' perceptions and readiness for digital health adoption.
Methodology: This cross-sectional survey involved 228 antenatal clients recruited through systematic sampling. Participants completed the 16-item Technology Readiness Index (TRI 2.0) and supplementary perception scales on 5-point response scales. Respondents were categorised as explorers, pioneers, skeptics, paranoids, or laggards based on their TRI scores. The range of Cronbach's alpha for scales was: 0.80-0.92. Data were analysed using SPSS version 29, applying descriptive and generalised linear regression analyses, with statistical significance set at p ≤ 0.05.
Results: The response rate was 100% and most participants were aged 25-34 (43.9%), married (51.8%), and held tertiary education (38.6%). Ownership of digital devices was smartwatches (6.1%), smartphones (25.9%), and computers (26.3%). Clients prioritised e-prescription (3.09±1.11) and access to personal health information (3.08±1.13) as top benefits of remote services. TRI Scores were overall TRI (3.00±0.31), optimism (3.12), innovativeness (3.22), discomfort (3.12), and insecurity (3.19). Majority (90.4%) were classified as skeptics. Unemployed clients showed lower acceptance of devices for remote maternal monitoring (B = -0.13, 95% CI: -0.24, -0.01, p = 0.033).
Conclusion: Despite the global momentum toward digital maternal health solutions, antenatal clients in Nigeria demonstrate low digital engagement and are predominantly skeptics. Targeted interventions including digital literacy campaigns, improved trust through data privacy protections, and broader infrastructural investments are critical for promoting equitable adoption of remote digital maternal health solutions.
背景:数字技术为监测孕妇提供了有希望的解决方案,但尼日利亚客户对采用数字技术的准备程度仍未得到充分探索。本研究评估了产前客户对数字健康采用的看法和准备情况。方法:本横断面调查涉及228名产前客户通过系统抽样招募。参与者完成了16个项目的技术准备指数(TRI 2.0)和5分制的补充感知量表。根据受访者的TRI分数,他们被分为探索者、开拓者、怀疑论者、偏执狂或落后者。量表的Cronbach’s alpha值范围为:0.80-0.92。数据分析采用SPSS version 29,采用描述性和广义线性回归分析,p≤0.05为统计学显著性。结果:调查问卷的回复率为100%,其中年龄在25-34岁(43.9%)、已婚(51.8%)、大专(38.6%)者居多。数字设备的拥有量分别是智能手表(6.1%)、智能手机(25.9%)和电脑(26.3%)。客户认为电子处方(3.09±1.11)和获取个人健康信息(3.08±1.13)是远程服务的最大好处。TRI得分为总体TRI(3.00±0.31)、乐观(3.12)、创新(3.22)、不适(3.12)、不安全感(3.19)。大多数(90.4%)被归为怀疑论者。失业客户对远程产妇监测设备的接受程度较低(B = -0.13, 95% CI: -0.24, -0.01, p = 0.033)。结论:尽管全球朝着数字化孕产妇保健解决方案发展势头强劲,但尼日利亚产前服务客户的数字化参与度较低,主要持怀疑态度。有针对性的干预措施,包括数字扫盲运动、通过数据隐私保护改善信任以及更广泛的基础设施投资,对于促进公平采用远程数字孕产妇保健解决方案至关重要。
{"title":"Digital Technology-Enhanced Remote Health Services: Antenatal Clients' Perception, Acceptance and Readiness at a Nigerian Tertiary Hospital.","authors":"Leeleebari Rachael Deekae, Daniel Lekue Denebari, Happiness Chinaza Dick, Daprim Samuel Ogaji","doi":"10.71480/nmj.v66i4.1013","DOIUrl":"10.71480/nmj.v66i4.1013","url":null,"abstract":"<p><strong>Background: </strong>Digital technology offers promising solutions for monitoring pregnant women but client's readiness for its adoption in Nigeria remains underexplored. This study assessed antenatal clients' perceptions and readiness for digital health adoption.</p><p><strong>Methodology: </strong>This cross-sectional survey involved 228 antenatal clients recruited through systematic sampling. Participants completed the 16-item Technology Readiness Index (TRI 2.0) and supplementary perception scales on 5-point response scales. Respondents were categorised as explorers, pioneers, skeptics, paranoids, or laggards based on their TRI scores. The range of Cronbach's alpha for scales was: 0.80-0.92. Data were analysed using SPSS version 29, applying descriptive and generalised linear regression analyses, with statistical significance set at p ≤ 0.05.</p><p><strong>Results: </strong>The response rate was 100% and most participants were aged 25-34 (43.9%), married (51.8%), and held tertiary education (38.6%). Ownership of digital devices was smartwatches (6.1%), smartphones (25.9%), and computers (26.3%). Clients prioritised e-prescription (3.09±1.11) and access to personal health information (3.08±1.13) as top benefits of remote services. TRI Scores were overall TRI (3.00±0.31), optimism (3.12), innovativeness (3.22), discomfort (3.12), and insecurity (3.19). Majority (90.4%) were classified as skeptics. Unemployed clients showed lower acceptance of devices for remote maternal monitoring (B = -0.13, 95% CI: -0.24, -0.01, p = 0.033).</p><p><strong>Conclusion: </strong>Despite the global momentum toward digital maternal health solutions, antenatal clients in Nigeria demonstrate low digital engagement and are predominantly skeptics. Targeted interventions including digital literacy campaigns, improved trust through data privacy protections, and broader infrastructural investments are critical for promoting equitable adoption of remote digital maternal health solutions.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1608-1622"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746321/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145867033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11eCollection Date: 2025-07-01DOI: 10.71480/nmj.v66i4.999
Asmau Usman, Lawal Shuaibu, Abubakar Dahiru, Shuaibu Adam
Embryonal rhabdomyosarcoma is a distinct subtype of rhabdomyosarcoma commonly seen in children less than 5 years of age, but it can appear at any age. It's frequently seen at the head and neck region, but rare sites include the ear. It often presents with facial nerve palsy. We present two extraordinary cases of embryonal rhabdomyosarcoma in the middle ear in a 3-year-old boy and girl.
{"title":"Rare Presentations of Embryonal Rhabdomyosarcoma in the Middle Ear of a 3-Year-Old Boy and Girl.","authors":"Asmau Usman, Lawal Shuaibu, Abubakar Dahiru, Shuaibu Adam","doi":"10.71480/nmj.v66i4.999","DOIUrl":"10.71480/nmj.v66i4.999","url":null,"abstract":"<p><p>Embryonal rhabdomyosarcoma is a distinct subtype of rhabdomyosarcoma commonly seen in children less than 5 years of age, but it can appear at any age. It's frequently seen at the head and neck region, but rare sites include the ear. It often presents with facial nerve palsy. We present two extraordinary cases of embryonal rhabdomyosarcoma in the middle ear in a 3-year-old boy and girl.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1694-1702"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145867095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11eCollection Date: 2025-07-01DOI: 10.71480/nmj.v66i4.878
Tamunokuro Ezekiel Diamond, Mike Tochi Achor
Achilles tendon injuries are commonly encountered in orthopaedic practice. The Achilles tendon is prone to rupture, and this negatively imparts ambulation. The diagnosis is clinical. Treatment options have evolved from conservative to surgeries, however there is no consensus on the most superior option of treatment. This narrative review aims to highlight the evolution in clinical diagnosis and treatment of Achilles tendon ruptures and discuss the current evidence in the treatment with emphasis on outcome measures of each treatment modality. Relevant studies on Achilles tendon ruptures with emphasis on treatment options, their strengths and weaknesses were reviewed. The treatment of Achilles tendon rupture has evolved from conservative options to surgeries. The surgical options include open repair, percutaneous repair, endoscopic repair, and ultrasound-guided repair. However, there is still no consensus on the most superior option for treating Achilles tendon injuries. Each method has its pros and cons. Conservative treatment has the appeal of the absence of scars, low cost and shorter duration of hospital stay. However, ankle stiffness, and late return to work are important drawbacks. Open surgery has the advantage of early return to function and low re-intervention rates. Surgical scars, likelihood of infection and cost are major disadvantages. Appropriate patient selection guided by the severity of the injury, the age of the patient, pre-injury status, work demand for the patient, experience of the surgeon, available resources, local soft tissue condition, and the patient's preferences are key to successful outcome.
{"title":"Current Concepts in the Management of Achilles Tendon Injuries.","authors":"Tamunokuro Ezekiel Diamond, Mike Tochi Achor","doi":"10.71480/nmj.v66i4.878","DOIUrl":"10.71480/nmj.v66i4.878","url":null,"abstract":"<p><p>Achilles tendon injuries are commonly encountered in orthopaedic practice. The Achilles tendon is prone to rupture, and this negatively imparts ambulation. The diagnosis is clinical. Treatment options have evolved from conservative to surgeries, however there is no consensus on the most superior option of treatment. This narrative review aims to highlight the evolution in clinical diagnosis and treatment of Achilles tendon ruptures and discuss the current evidence in the treatment with emphasis on outcome measures of each treatment modality. Relevant studies on Achilles tendon ruptures with emphasis on treatment options, their strengths and weaknesses were reviewed. The treatment of Achilles tendon rupture has evolved from conservative options to surgeries. The surgical options include open repair, percutaneous repair, endoscopic repair, and ultrasound-guided repair. However, there is still no consensus on the most superior option for treating Achilles tendon injuries. Each method has its pros and cons. Conservative treatment has the appeal of the absence of scars, low cost and shorter duration of hospital stay. However, ankle stiffness, and late return to work are important drawbacks. Open surgery has the advantage of early return to function and low re-intervention rates. Surgical scars, likelihood of infection and cost are major disadvantages. Appropriate patient selection guided by the severity of the injury, the age of the patient, pre-injury status, work demand for the patient, experience of the surgeon, available resources, local soft tissue condition, and the patient's preferences are key to successful outcome.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1301-1314"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12778369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145936929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Human Immunodeficiency Virus (HIV) remains a major public health concern in Nigeria, which has been rated as having a high HIV burden globally. Antiretroviral therapy (ART) has significantly improved life expectancy and reduced HIV-related morbidity and mortality. However, ART is associated with adverse drug reactions (ADRs), which can lead to treatment failure, regimen changes, and non-adherence, ultimately affecting patient outcomes.
Methodology: This was a retrospective cohort study of newly initiated people living with HIV (PLHIV) accessing care at the Lagos State University Teaching Hospital (LASUTH), Ikeja. All newly initiated HIV patients receiving antiretroviral therapy (ART) at LASUTH between March 2023 and March 2025 were included. Data collected during the study period were abstracted, and individuals who experienced an adverse drug reaction (ADR) were recorded. Data was analysed using the Statistical Package for the Social Sciences (SPSS) version 27.0. Statistical significance was established at p ≤ 0.5.
Results: Overall, 533 newly initiated into treatment in the study period. Out of the newly initiated (533), a total of 65 reported adverse reactions to the drugs of treatment, which constituted 12.1% prevalence of ADR in the newly initiated. The mean age of all participants was 40.50 ± 11.76 years. All the newly initiated (100%) were on Tenofovir, Lamivudine, and Dolutegravir (TLD) combination. Pruritus is the commonest symptom in both females and males.
Conclusion: The ADR prevalence among the newly enrolled PLHIV is 12% and pruritus is the commonest ADR seen among the newly enrolled.
{"title":"Prevalence of Adverse Drug Reactions among People Living with HIV in Lagos State University Teaching Hospital, Lagos, Nigeria.","authors":"Christiana Ayodeji Olaniyi, Akinsegun Abduljaleel Akinbami, Ebele Ifeayinwa Uche, Abimbola Olubukunola Odubona, Shola Shinen Jinadu, Omobolanle Taofikoh Akinbami, Rotimi Ayodeji Dawodu","doi":"10.71480/nmj.v66i4.893","DOIUrl":"10.71480/nmj.v66i4.893","url":null,"abstract":"<p><strong>Background: </strong>Human Immunodeficiency Virus (HIV) remains a major public health concern in Nigeria, which has been rated as having a high HIV burden globally. Antiretroviral therapy (ART) has significantly improved life expectancy and reduced HIV-related morbidity and mortality. However, ART is associated with adverse drug reactions (ADRs), which can lead to treatment failure, regimen changes, and non-adherence, ultimately affecting patient outcomes.</p><p><strong>Methodology: </strong>This was a retrospective cohort study of newly initiated people living with HIV (PLHIV) accessing care at the Lagos State University Teaching Hospital (LASUTH), Ikeja. All newly initiated HIV patients receiving antiretroviral therapy (ART) at LASUTH between March 2023 and March 2025 were included. Data collected during the study period were abstracted, and individuals who experienced an adverse drug reaction (ADR) were recorded. Data was analysed using the Statistical Package for the Social Sciences (SPSS) version 27.0. Statistical significance was established at p ≤ 0.5.</p><p><strong>Results: </strong>Overall, 533 newly initiated into treatment in the study period. Out of the newly initiated (533), a total of 65 reported adverse reactions to the drugs of treatment, which constituted 12.1% prevalence of ADR in the newly initiated. The mean age of all participants was 40.50 ± 11.76 years. All the newly initiated (100%) were on Tenofovir, Lamivudine, and Dolutegravir (TLD) combination. Pruritus is the commonest symptom in both females and males.</p><p><strong>Conclusion: </strong>The ADR prevalence among the newly enrolled PLHIV is 12% and pruritus is the commonest ADR seen among the newly enrolled.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1459-1466"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12778368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145936919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11eCollection Date: 2025-07-01DOI: 10.71480/nmj.v66i4.789
Sarah Abere, Ozuomba Sixtus, Ngozi Koko-James
Background: Helicobacter pylori (H. pylori) infection is a significant public health concern, contributing to various gastrointestinal disorders, including peptic ulcers and gastric cancer. The infection is highly prevalent in Africa, but still diagnostic and treatment challenges persist in primary care settings. Effective treatment regimens are therefore crucial for eradicating this infection and preventing complications. This study aimed to develop a consensus-based algorithm for H. pylori management optimized for Primary care settings utilizing data from primary care physicians, patient screening, and treatments.
Methodology: A cross-sectional study was conducted among forty-four primary care physicians involved in diagnosing and treating H. pylori infection. They were provided with a data Collection Form (DCF) and an H. pylori rapid antibody test kit. All the questionnaire responses and the result of rapid antibody test were recorded and analyzed. A panel of experts involving senior family medicine doctors, and a gastroenterologist via a modified Delphi process of discussions on the DCF responses, and test results from the 44 physicians arrived at a consensus-based treatment algorithm developed to guide clinical decision-making for H. pylori management.
Results: This study comprised 245 patients with a female preponderance and mean age of 35.0±11.5 years. The most common symptoms from the DCF were epigastric pain, nausea/vomiting and bloating in 74.5%, 52.7% and 35% respectively while the mean duration of symptoms was 3weeks. Constipation and irritability were the least common symptoms with heartburn reported less frequently in the H. Pylori positive cases. 79.9% of the 245 patients were H. Pylori treatment naïve with a higher likelihood (57.1%) of having a positive antibody test. It was recommended that both treatment experienced and naïve patients with epigastric or abdominal pain, nausea vomiting and/or bloating with symptom duration > 2weeks be tested and eradicated while those with alarm symptoms be referred to the specialist.
Conclusion: The proposed algorithm provides a comprehensive guide for Physicians at the primary and secondary care level in selecting the most effective treatment regimen for H. pylori infection. H. Pylori antibody testing is a primary screening tool for patients with persistent symptoms or those lasting greater than 2weeks and where positive confirmatory test is recommended.
{"title":"Establishing a Consensus Algorithm for H. Pylori Screening, Diagnosis, Initial Management, and Referral Protocols for Primary Care Physicians.","authors":"Sarah Abere, Ozuomba Sixtus, Ngozi Koko-James","doi":"10.71480/nmj.v66i4.789","DOIUrl":"10.71480/nmj.v66i4.789","url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori (H. pylori) infection is a significant public health concern, contributing to various gastrointestinal disorders, including peptic ulcers and gastric cancer. The infection is highly prevalent in Africa, but still diagnostic and treatment challenges persist in primary care settings. Effective treatment regimens are therefore crucial for eradicating this infection and preventing complications. This study aimed to develop a consensus-based algorithm for H. pylori management optimized for Primary care settings utilizing data from primary care physicians, patient screening, and treatments.</p><p><strong>Methodology: </strong>A cross-sectional study was conducted among forty-four primary care physicians involved in diagnosing and treating H. pylori infection. They were provided with a data Collection Form (DCF) and an H. pylori rapid antibody test kit. All the questionnaire responses and the result of rapid antibody test were recorded and analyzed. A panel of experts involving senior family medicine doctors, and a gastroenterologist via a modified Delphi process of discussions on the DCF responses, and test results from the 44 physicians arrived at a consensus-based treatment algorithm developed to guide clinical decision-making for H. pylori management.</p><p><strong>Results: </strong>This study comprised 245 patients with a female preponderance and mean age of 35.0±11.5 years. The most common symptoms from the DCF were epigastric pain, nausea/vomiting and bloating in 74.5%, 52.7% and 35% respectively while the mean duration of symptoms was 3weeks. Constipation and irritability were the least common symptoms with heartburn reported less frequently in the H. Pylori positive cases. 79.9% of the 245 patients were H. Pylori treatment naïve with a higher likelihood (57.1%) of having a positive antibody test. It was recommended that both treatment experienced and naïve patients with epigastric or abdominal pain, nausea vomiting and/or bloating with symptom duration > 2weeks be tested and eradicated while those with alarm symptoms be referred to the specialist.</p><p><strong>Conclusion: </strong>The proposed algorithm provides a comprehensive guide for Physicians at the primary and secondary care level in selecting the most effective treatment regimen for H. pylori infection. H. Pylori antibody testing is a primary screening tool for patients with persistent symptoms or those lasting greater than 2weeks and where positive confirmatory test is recommended.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 4","pages":"1374-1385"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145954892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}